These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 25613425

  • 1. GM3 and cancer.
    Hakomori SI, Handa K.
    Glycoconj J; 2015 Feb; 32(1-2):1-8. PubMed ID: 25613425
    [Abstract] [Full Text] [Related]

  • 2. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
    Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S.
    J Biol Chem; 2005 Oct 21; 280(42):35545-53. PubMed ID: 16103120
    [Abstract] [Full Text] [Related]

  • 3. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
    Toledo MS, Suzuki E, Handa K, Hakomori S.
    J Biol Chem; 2005 Apr 22; 280(16):16227-34. PubMed ID: 15710618
    [Abstract] [Full Text] [Related]

  • 4. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
    Miura Y, Kainuma M, Jiang H, Velasco H, Vogt PK, Hakomori S.
    Proc Natl Acad Sci U S A; 2004 Nov 16; 101(46):16204-9. PubMed ID: 15534203
    [Abstract] [Full Text] [Related]

  • 5. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI.
    Carbohydr Res; 2009 Aug 17; 344(12):1479-86. PubMed ID: 19559406
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
    Todeschini AR, Dos Santos JN, Handa K, Hakomori SI.
    J Biol Chem; 2007 Mar 16; 282(11):8123-33. PubMed ID: 17215249
    [Abstract] [Full Text] [Related]

  • 12. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
    Li Y, Huang X, Zhang J, Li Y, Ma K.
    Int J Biochem Cell Biol; 2013 Nov 16; 45(11):2349-58. PubMed ID: 23968914
    [Abstract] [Full Text] [Related]

  • 13. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
    Wang XQ, Yan Q, Sun P, Liu JW, Go L, McDaniel SM, Paller AS.
    Cancer Res; 2007 Oct 15; 67(20):9986-95. PubMed ID: 17942932
    [Abstract] [Full Text] [Related]

  • 14. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility.
    Hakomori SI.
    FEBS Lett; 2010 May 03; 584(9):1901-6. PubMed ID: 19874824
    [Abstract] [Full Text] [Related]

  • 15. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
    Regina Todeschini A, Hakomori SI.
    Biochim Biophys Acta; 2008 Mar 03; 1780(3):421-33. PubMed ID: 17991443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced expression of membrane-associated sialidase Neu3 decreases GD3 and increases GM3 on the surface of Jurkat cells during etoposide-induced apoptosis.
    Azuma Y, Sato H, Higai K, Matsumoto K.
    Biol Pharm Bull; 2007 Sep 03; 30(9):1680-4. PubMed ID: 17827720
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
    Huang X, Li Y, He X, Chen Y, Wei W, Yang X, Ma K.
    Mol Med Rep; 2020 Nov 03; 22(5):3994-4002. PubMed ID: 33000220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.